Endothelin 2 (ET2), also referred to as vasoactive intestinal contractor peptide, is a member of a family of soa active peptides. ET2 is a potent constrictor of intestinal smooth muscle, and the mRNA that encodes it has been detected in murine intestinal extracts. To further investigate the potential physiological roles of ET2, we characterized the cellular distribution of ET2 gene expression in adult rat gastrointestinal tract. Using an RNAse protection assay, an overall proximal to distal gradient of increasing ET2 gene expression was observed from stomach to colon. In situ hybridization studies confumed this fmding and demonstrated ET2 mRNA local-
Introduction
The endothelin genes encode a family of potent vasoactive peptides (I), but their expression in non-endothelial cells suggests a more diverse role for these molecules (2) (3) (4) . Non-vascular activities of endothelins include their ability to stimulate contraction of intestinal ( 5 ) and bronchial (6) smooth muscle, to function as neurotransmitters (2), and to stimulate gluconeogenesis (7) . Previous studies demonstrated that the gene encoding one member of the endothelin gene family, vasoactive intestinal contractor (VIC), is expressed in the intestine ( 5 3). Recently, our laboratory characterized genomic sequences encoding rat VIC and demonstrated that VIC is the mouse and rat analogue of the human endothelin 2 (ET2) gene (9). The present study was designed to identify the cellular distribution of ET2 gene expression to gain insight into the possible roles ofthis peptide in gastrointestinal physiology. Using RNAse protection assays and in situ hybridization, we investigated the expression of the gene that encodes ET2 in rat gastrointestinal tissues.
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Materials and Methods
Isolation of Endothelin Gene Probes: The ET2 gene was isolated from a rat genomic DNA library as described previously (9). A 333 BP PstI restriction endonuclease fragment containing sequences encoding rat ET2 was cloned into pGEM3 (pGEM3-ET2). The ET1 gene was isolated from the same rat genomic library using a radiolabeled restriction fragment of a human ET1 cDNA (10). A 141 BP SacI/HincII restriction fragment containing ET1 exon 2 sequences was subcloned into pGEM4 (pGEM4-ET1).
RNAse Protection Assay. Seven adult rats (300 g) were sacrificed with diethyl ether anesthesia and segments of the stomach, duodenum, jejunum, ileum, and colon were excised. RNA was isolated by extraction with guanidinium isothiocyanate, followed by centrifugation through a cesium chloride stepgradient (11). ET1 and ET2 mRNA levels were measured in an RNAse protection assay as described previously (12). To prepare a uniformly labeled anti-sense ET2 cRNA probe, pGEM3-ET2 was linearized with PvuII and incubated with SP6 RNA polymerase in the presence of [3*P]-UTP. An anti-sense ET1 cRNA probe was similarly prepared, except that pGEM4-ET1 was linearized with EcoRI and was incubated with T7 RNA polymerase. Cellular RNA (10 pg) was hybridized with ET1 and ET2 cRNA probes in separate reactions (12). A radiolabeled anti-sense cRNA probe for human y-actin (13) was added to each hybridization to confirm that equal concentrations of RNA were hybridized. RNA fragments protected from RNAse were fractionated on a 5 % urea-polyacrylamide gel. Hybridization of RNA probes with ET2 and ET1 mRNAs protected predominantly 138-and 141-nucleotide radiolabeled fragments, respectively. Rat y-actin mRNA protected an approximately 80-nucleotide fragment of human y-actin probe. Non-saturated autoradiographs were subjected to volume densitometric scanning using an ImageQuant Analysis system to quantify the relative abundance of ET1, ET2, and y-actin mRNA expression. Volume densitometry scanning data are represented with arbitrary units, but depict relative differences in signal intensity.
Tissue Preparation for In Situ Hybridization. Tissues from seven rats were immersion-fixed in 4% paraformaldehyde prepared in PBS (10 mM sodium phosphate, 1.5 M NaCI. pH 7.4) and embedded in paraffin. Paraffin sections (10 pm thick) were mounted on gelatin-coated slides and used for in situ hybridization. Before use. the sections were heated for 15 min at 60'C to promote adherence to the glass and melt the paraffin. The sections were dewaxed in xylenes, hydrated through graded alcohol solutions, and equilibrated in PBS.
In Situ Hybridization. ET1 and ET2 cRNA probes used for in situ hybridization were prepared as described above, except that they were labeled with [3'SJ-UTP. Before hybridization, the sections were treated with 0.2 N HCI for 5 min at room temperature (RT), followed by 1 pglml of proteinase K (37'C). The sections were equilibrated with 0.1 M triethanolamine, pH 8.0, and then acetylated with 0.025% acetic anhydride in 0.1 M triethanolamine, pH 8.0 (RT). RNA was denatured in 50% formamidel 2 x SSC for 15 min at 42'C. The sections were dehydrated through graded alcohols and air-dried before the application of probe. The tissues were hybridized for 12 hr at 50'c with approximately 5 x IO' dpm of "Slabeled anti-sense cRNA probekm2 of tissue in a hybridization solution containing 50% formamide, 4 x SSPE, 10 mM sodium pyrophosphate, 1 x Denhardt's solution, 200 mM IYlT 300 pglml denatured salmon sperm DNA, 100 pglml tRNA. 10% PEG 6000, and 1% SDS. The slides were washed for 1 hr (SOT) in 4 x SSC, 10 mM DTT. 50% formamide, and 0.5% Triton X-100. Unhybridized cRNA probe was digested with 50 pglml RNAse A in a solution containing 0.5 M NaCI, 10 mM ais, 1 mM EDTA, pH 8.0, and 10 mM IYlT Sections were further washed for30 min each at 37'C in 2 x SSC with 1 mM MT and then 0.2 x SSC with 1 mM DTI: The sections were dehydrated through graded alcohol soluuons containing 0.3 M ammonium acetate. The slides were exposed with Kodak N T s 2 emulsions for 1-2 weeks and then developed in Kodak Dl9 according to the manufacturer's protocol. The sections were stained with hematoxylin, dehydrated, cleared in xylenes, and preserved under coverslips with Permount.
Results

ET2 and ET1 Expression by RNAse Protection Assay
ET2 mRNA was detected in adult rat intestine but not in adrenal gland, atria, ventricle, brain, liver, placenta, spleen, or testis (data not shown). Moreover, ET2 mRNA was not detected in lung or kidney from late-gestation fetal or adult rats. The level of ET2 mRNA in the gastrointestinal tract exhibited an overall proximal to distal gradient of increasing expression ( Figures 1A and 1C ). ET2 mRNA was not detected in the stomach, and low levels were detected in the duodenum. Expression was lower in the jejunum compared with the ileum, and lower in the ileum compared with the colon. However, the levels of ET2 mRNA appeared to be higher in the proximal than in the distal jejunum. In contrast, there were no appreciable regional differences in the levels of 7-actin mRNA (Figures 1A  and 1B ). ET1 mRNA, on the other hand, was detected throughout the gastrointestinal tract, with high levels observed in the stomach and colon, and lower, relatively uniform levels observed throughout the small intestine ( Figures 1B and IC) .
In Situ Hybridization
Both the rat ET1 and ET2 cRNA probes hybridized primarily in lamina propria cells, but the ET1 probe also hybridized with vascular endothelial cells and ganglion cells in the muscularis layers (Figures 2 and 3) . In contrast, the ET2 probe did not hybridize with endothelial cells. Within the lamina propria, it was difficult to determine which specific cell populations were labeled by in situ hybridization. The hybridization signal appeared to be localized mainly to smooth muscle cells and fibroblasts, whereas endothelial cells were not labeled.
In addition to dissimilarities in cellular distribution, the regional levels of ET1 and ET2 mRNA expression also differed strikingly throughout the gastrointestinal tract ( Figure 3 ). As demonstrated by RNAse protection assay, ET1 expression in stomach was high, whereas ET2 mRNA levels were very low. In the duodenum, the levels of ET1 mRNA were also markedly higher than the levels of ET2 by in situ hybridization. In the jejunum, the levels of ET1 and ET2 mRNA were similar, although the distribution within the in-testinal mucosa differed. ET1 mRNA was uniformly distributed in the lamina propria, whereas ET2 mRNA was most prominent within the lamina propria subjacent to the luminal (most mature) epithelial cells, and it was least evident in association with basal epithelial cells (Figure 3 ). The same finding was observed in the ileum but, in addition, the overall levels of ET1 mRNA were lower than in more proximal regions ofthe gastrointestinal tract. Throughout the colon, the levels of ET1 mRNA were higher than the levels of ET2 and, for both, the mRNA levels were higher in the descending colon than in the ascending colon. Again, ET1 mRNA expression was primarily distributed in endothelial cells, lamina propria cells, and myenteric and submucosal ganglion cells. In the colon, ET2 mRNA was detected in the lamina propria cells. Overall, the relative differences in the levels of ET1 and ET2 mRNA observed in different regions of the gastrointestinal tract by RNAse protection assay were confirmed by in situ hybridization. The variability in results obtained with these two methods could have been due to dfirences in the specific segments of the gut that were examined.
The specificity of hybridization with the ET2 cRNA probe was demonstrated in two ways. First, the patterns of expression observed by RNAse protection were different for ET1 and ET2. The proximal to distal gradient observed for ET2 was not detected with the ET1 probe. Second, by in situ hybridization, the prominent endothelial cell labeling observed in the gastrointestinal tract as well as in other tissues with the ET1 probe was not observed with the ET2 probe. For example, the ET1 cRNA probe hybridized with cardiac and cerebral vascular endothelial cells, whereas the ET2 cRNA probe did not. Lymphomononuclear cells and Peyer's patch cells were hybridized with the ET1 but not with the ET2 cRNA probe. Finally, neither the ET2 nor the ET1 probe generated in situ hybridization signals when the tissues were pre-treated with 100 Wglml of RNAse A for 1 hr at 37°C (data not shown).
Discussion
This study demonstrates regional variation in the levels of ET1 and ET2 gene expression in the rat gastrointestinal tract using RNAse protection assay and in situ hybridization. By both in situ hybridization and RNAse protection analysis, ET1 mRNA expression was high in the stomach, low-level and uniform throughout the small intestines, and again high in the colon. This was precisely the observation reported previously using radioimmunoassay to detect ET1-immunoreactive peptide in the rat gastrointestinal tract (14). In contrast, for ET2 there was an overall proximal to distal gradient of increasing expression from stomach to the terminal ileum (in situ hybridization) or the colon (RNAse protection assay). By in situ hybridization, maximal ET2 expression was observed in the distal ileum and the lowest levels were in the stomach and duodenum. Although the levels of ET2 mRNA were lower in the colon than in the distal ileum by in situ hybridization, this was not the , (C,G) distal ileum, and (D,H) colon. Hybridization signals are represented by white grains. Arrows indicate serosal surface. L, luminal side. ET1 mRNA expression was detected in myenteric ganglion cells, and endothelial cells, with little regional variation within the small intestine. In contrast, ET2 mRNA levels varied, with a striking proximal to distal gradient of increasing expression. In addition, within the iejunum and the ileum, higher levels of ET2 mRNAwere detected in the villi than in the crypt regions (F,G). Bar = 80 vm. case with RNAse protection analysis. Subsequent studies demonstrated variability in the levels of ET2 gene expression in different regions ofthe colon, thereby accounting for the apparent discrepancy between in situ hybridization and RNAse protection results. More importantly, it is difficult to utilize in situ hybridization as a major tool for quantifying levels of a particular mRNA. Instead, the power of the method is in documenting cellular localization of gene expression in a heterogeneous population of cells contained within tissues.
ET2 mRNA was distributed primarily in lamina propria cells, which include smooth muscle and fibroblast elements. In contrast, ET1 mRNA was primarily distributed in endothelial cells and ganglion cells as described previously (3, 15) . The ET2 gene, on the other hand, was not expressed in endothelial cells, ganglion cells, and lymphoid cells. Specifically, ET2 mRNA expression was not detected in Peyer's patches or in lymphoid aggregates within the villi. Neither the ET1 nor the ET2 gene appeared to be expressed in gastrointestinal epithelial cells. Differences in the cellular distribution of ET1 and ET2 gene expression suggest different functions of these molecules. ET1 is a potent vasoactive peptide. At the same time, the localization of ET1 gene expression to central nervous system neurons (3, (15) (16) (17) (18) and in dorsal root ganglia (15) points towards its importance as a neuropeptide. ET2, which is the same as vasoactive intestinal contractor (VIC) (9), modulates intestinal smooth muscle tone ( 5 ) . The localization of ET2 gene expression in lamina propria cells may suggest a role for this peptide in local villous motility. In addition, the consistently higher levels of ET2 gene expression in villous cells compared with crypt stromal cells suggests that expression may be associated with epithelial cell maturation.
Because gastrointestinal epithelial cells possess endothelin receptors (19, it is conceivable that their endothelin immunoreactivity might reflect a paracrine type of adsorption, stimulation, and uptake of endothelin peptides secreted by endothelial cells, ganglion cells, or lamina propria cells. Alternatively, ET2 may modulate hepatic function (7) via the portal circulation. Endothelins are mitogenic for a variety of cell types (20) (21) (22) . The abundant ET2 gene expression in the lamina propria is consistent with its possible role in regulating proliferation of stromal cells. Of interest is that other intestinal peptides, such as transforming growth factors a and p (23,24) and vasoactive intestinal polypeptide (25) (26) (27) ) that exhibit regional and cellular maturation-associated differences in the level of gene expression, may also have autocrine or paracrine stimulatory effects on intestinal epithelial cell function.
The function of ET2 gene expression in the gastrointestinal tract is not clear. However, its distribution suggests both maturation and regional distribution. Both the maturation-associated and regional distributions correspond with secretory activity of the epithelial cells. It would therefore be of interest to investigate the potential role of ET2 gene expression in relation to intestinal disorders such as secretory diarrhea and inflammatory bowel diseases.
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